ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;85:102-107. doi:10.1016/j.athoracsur.2007.05.010
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eugene A. Grossi
Charles F. Schwartz
Gregory A. Crooke
Juan B. Grau
Greg H. Ribakove
F. Gregory Baumann
Alfred T. Culliford
Stephen B. Colvin
Aubrey C. Galloway
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grossi, E. A.
Right arrow Articles by Galloway, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grossi, E. A.
Right arrow Articles by Galloway, A. C.
Related Collections
Right arrow Valve disease

Original Articles: Cardiovascular

High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted?

Eugene A. Grossi, MDa,*, Charles F. Schwartz, MDa, Pey-Jen Yu, MDa, Ulrich P. Jorde, MDb, Gregory A. Crooke, MDa, Juan B. Grau, MDa, Greg H. Ribakove, MDa, F. Gregory Baumann, PhDa, Patricia Ursumanno, PhDa, Alfred T. Culliford, MDa, Stephen B. Colvin, MDa, Aubrey C. Galloway, MDa

a Department of Cardiothoracic Surgery, Division of Cardiology, New York University School of Medicine, New York, New York
b Department of Medicine, Division of Cardiology, New York University School of Medicine, New York, New York

Accepted for publication May 1, 2007.

* Address correspondence to Dr Grossi, New York University Medical Center, 530 First Ave, Ste 9V, New York, NY 10016 (Email: grossi{at}cv.med.nyu.edu).

Presented at the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.

Background: Percutaneous aortic valve replacement (PAVR) trials are ongoing in patients with an elevated European System for Cardiac Operative Risk Evaluation (EuroSCOREs), patients believed to have high mortality rates and poor long-term prognoses with valve replacement surgery. It is, however, uncertain that the EuroSCORE model is well calibrated for such high-risk AVR patients. We evaluated EuroSCORE prediction vs a single institution’s surgical results in this target population.

Methods: From January 1996 through March 2006, 731 patients with EuroSCOREs of 7 or higher underwent isolated AVR. In this cohort, 313 (42.8%) were septuagenarians, 322 (44.0%) were octogenarians or nonagenarians, 233 (31.9%) had had previous cardiac procedures, 237 (32.4%) had atheromatous aortas, and 127 (17.4%) had cerebrovascular disease. A minimally invasive approach was used in 469 (64.2%). Data collection was prospective. Long-term survival was computed from the Social Security Death Benefit Index.

Results: The mean EuroSCORE was 9.7 (median, 10), and the mean logistic EuroSCORE was 17.2%. Actual hospital mortality was 7.8% (57 of 731). Multivariate analysis showed ejection fraction of less than 0.30 (p = 0.002; odds ratio [OR], 3.13), chronic obstructive pulmonary disease (p = 0.019; OR, 2.14), and peripheral vascular disease (p = 0.048; OR, 2.13) were significant predictors of hospital mortality. Complication(s) occurred in 73 patients (9.9%). Freedom from all-cause death (including hospital mortality) was 72.4% at 5 years (n = 152). Age (p < 0.001), previous cardiac operations (p < 0.014; OR, 1.51), renal failure (p < 0.002; OR, 2.37), and chronic obstructive pulmonary disease (p < 0.007; OR, 1.30) were predictors of worse survival.

Conclusions: Logistic EuroSCORE greatly overpredicts mortality in these patients. Five-year survival is good, unlike suggestions from earlier EuroSCORE analyses. This raises concern about unknown long-term percutaneous prosthesis function. Clinical trials for these patients must include randomized surgical controls and have long-term end points.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
E. Manasse
Cooks and recipes
Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 787 - 790.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Thielmann, D. Wendt, H. Eggebrecht, P. Kahlert, P. Massoudy, M. Kamler, R. Erbel, H. Jakob, and S. Sack
Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement.
Ann. Thorac. Surg., November 1, 2009; 88(5): 1468 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Zierer, G. Wimmer-Greinecker, S. Martens, A. Moritz, and M. Doss
Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement?
J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1067 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. S. Likosky, M. J. Sorensen, L. J. Dacey, Y. R. Baribeau, B. J. Leavitt, A. W. DiScipio, F. Hernandez Jr, R. P. Cochran, R. Quinn, R. E. Helm, et al.
Long-Term Survival of the Very Elderly Undergoing Aortic Valve Surgery
Circulation, September 15, 2009; 120(11_suppl_1): S127 - S133.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. Wendt, B. R. Osswald, K. Kayser, M. Thielmann, P. Tossios, P. Massoudy, M. Kamler, and H. Jakob
Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement.
Ann. Thorac. Surg., August 1, 2009; 88(2): 468 - 474.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. Himbert, F. Descoutures, N. Al-Attar, B. Iung, G. Ducrocq, D. Detaint, E. Brochet, D. Messika-Zeitoun, F. Francis, H. Ibrahim, et al.
Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis.
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 303 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Al-Attar, D. Himbert, F. Descoutures, B. Iung, R. Raffoul, D. Messika-Zeitoun, E. Brochet, F. Francis, H. Ibrahim, A. Vahanian, et al.
Transcatheter Aortic Valve Implantation: Selection Strategy Is Crucial for Outcome.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1757 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Zajarias and A. G. Cribier
Outcomes and Safety of Percutaneous Aortic Valve Replacement
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1829 - 1836.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. Bleiziffer, H. Ruge, D. Mazzitelli, C. Schreiber, A. Hutter, J.-C. Laborde, R. Bauernschmitt, and R. Lange
Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 615 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Piazza, Y. Onuma, P. de Jaegere, and P. W. Serruys
Guidelines for reporting mortality and morbidity after cardiac valve interventions--need for a reappraisal?
Ann. Thorac. Surg., February 1, 2009; 87(2): 357 - 358.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
N. Khaladj, M. Shrestha, S. Peterss, I. Kutschka, M. Strueber, L. Hoy, A. Haverich, and C. Hagl
Isolated surgical aortic valve replacement after previous coronary artery bypass grafting with patent grafts: is this old-fashioned technique obsolete?
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 260 - 264.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
T. Walther, J. Kempfert, and M. A. Borger
Reply to Apostolakis et al.
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 377 - 378.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
E. E. Apostolakis, K. Akinosoglou, and D. Dougenis
On-pump or off-pump transapical aortic valve implantation provides better clinical outcomes?
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 376 - 377.
[Full Text] [PDF]

Home page
 ESC Textbook of Cardiovascular MedicineHome page
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper
CHAPTER 21 Valvular Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
V. H. Thourani, R. Myung, P. Kilgo, K. Thompson, J. D. Puskas, O. M. Lattouf, W. A. Cooper, J. D. Vega, E. P. Chen, and R. A. Guyton
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective
Ann. Thorac. Surg., November 1, 2008; 86(5): 1458 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. J. Antunes
Percutaneous aortic valve implantation. The demise of classical aortic valve replacement?
Eur. Heart J., June 1, 2008; 29(11): 1339 - 1341.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.